Join the Population Council's Center for Biomedical Research for a seminar series presentation on Thursday, March 16 at 9:30am EST titled “Pharmacogenomics and exogenous steroid hormones” presented by guest lecturer Dr. Aaron Lazorwitz.
Dr. Lazorwitz will present on how pharmacogenomic research in many other fields of medicine have led to the development of clinical tools that allow healthcare providers to use a patient's individual genetics to guide drug prescribing to improve efficacy and reduce side effects. Missing from these pharmacogenomic guidelines are exogenous steroid hormones, despite the high prevalence of use for these medications for over half the population. In this presentation, we will review the science of pharmacogenomic research and explore both the pharmacogenomic research that has been done with exogenous steroid hormones so far and future personalized medicine opportunities within the field.
The CTI Exchange hosted speaker, Dr. Aaron Lazorwitz, in the webinar "Pharmacogenomics and Contraceptive Choice Webinar." View it here.
Presenter bio: Dr. Lazorwitz, MD, is board certified in obstetrics and gynecology and earned his Bachelor of Arts in psychology from Johns Hopkins University. He then went to medical school at UT Southwestern Medical Center in Dallas and completed his residency at the University of Colorado. He remained at the University of Colorado for his fellowship in family planning and also received a master’s in clinical science from the University of Colorado during that time. Dr. Lazorwitz pursued specialist training in family planning so he could help provide comprehensive reproductive healthcare to even the most medically complicated patients. He is passionate about providing the full range of contraceptive options to his patients, including sterilization options. Dr. Lazorwitz also spends a large portion of his time involved in research activities and is interested in better understanding how genetic differences influence hormonal contraception.
תגובות